Twist Bioscience delivers cost-effective NGS solutions and edges higher to $91.55

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience up 0.24% today

Highlights

TWST maintains a strong bullish structure across all timeframes, trading near highs well above key support levels.
Momentum indicators are largely bullish, but short-term signals show a potential pause or slight overbought risk after recent gains.
The forecasted range for the coming week is $86.00 to $96.00, with consolidation likely unless price breaks above $94.10 or below $91.44.

Emily Leproust said researchers achieve deeper, more reliable data with fewer sequencing reads per sample compared to arrays and competing NGS panels. Details are being clarified.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish trend structure as resistance emerges near Ichimoku Kijun

TWST is trading at $91.55, just above the MA-20 at $91.44, firmly above the MA-50 at $83.51, and well above the MA-200 at $52.58. This confirms an established bullish structure across short-, medium-, and long-term trends. The Ichimoku Kijun sits at $94.10, which is currently above the price and therefore signals immediate resistance. Near-term support is seen at MA-20 ($91.44), with key support at MA-50 ($83.51). Immediate resistance is marked by the Kijun ($94.10), with key resistance at the MA-100 ($67.90), but this MA is not actionable as it lies too far below the current price.

Divergent short-term momentum as overbought risk builds amid recent gains

Momentum indicators show a strong upward bias with MACD and ADX on D1 both signaling buy. D1 RSI is moderately bullish at 53.19, while the Stoch RSI and CCI are both neutral, highlighting a pause in upward momentum. BBP on D1 registers as overbought, suggesting that recent buyer activity is dominating intraday dynamics. The Awesome Oscillator on D1 points to selling, which stands in contrast to otherwise bullish signals, creating a divergence in short-term momentum cues. Over the past week, TWST has risen $1.28 (1.42%), climbing from a previous weekly close of $90.27. The price is currently in the upper part of this week’s range, and weekly volatility stands at 15.11%. After rebounding strongly from its weekly low, the tone is one of continued strength with some overbought risk.

Price consolidation favored as upside bias dominates volatility range

Looking ahead, the forecasted price range for the coming week is $86.00 to $96.00, adjusted to reflect the current price and typical weekly volatility. Probability modeling, based on W1 indicators, assigns a very high probability (more than 80%) to a continued price increase, with a much lower chance for a decline. The baseline scenario is for TWST to consolidate between recent support and resistance. A bullish scenario would see a move above $94.10, potentially targeting the upper $96.00 zone. Conversely, a break below $91.44 could see the price testing $86.00. This range holds TWST near the upper portion of its 52-week band ($23.30–$105.41), underscoring strong year-to-date momentum.

Earlier, analysts noted that Twist Bioscience exhibited strong bullish momentum, underpinned by sustained buyer interest but tempered by cautionary overbought signals. In the current context, investors should closely monitor for potential shifts in momentum as new resistance levels emerge, with the prevailing scenario focused on whether buyers can hold control above short-term support.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.